glycyrrhizic acid has been researched along with cysteine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, M; Koike, M; Miyashiro, E; Sumiyama, K | 1 |
| Wang, JT | 1 |
| Ishii, M; Miura, M; Miyazaki, Y; Takahashi, T; Toyota, T; Ueno, Y; Yamamoto, T | 1 |
| Abo, T; Makino, M; Miyaji, C; Watanbe, H | 1 |
| Hashimoto, A; Hozu, S; Kurokawa, I; Umehara, M | 1 |
| Furutani, T; Gondo, T; Hidaka, I; Hino, K; Kawano, H; Korenaga, M; Nishina, S; Sakai, A; Sakaida, I; Shinozaki, A | 1 |
| Rino, Y; Yamamoto, N; Yukawa, N | 1 |
| Horikiri, T; Kaneko, Y; Kinoshita, A; Kurita, Y; Kuwano, K; Odashima, K; Saito, Z; Seki, A; Seki, Y; Takeda, H; Yoshii, Y | 1 |
| Antoniv, A; Kanovska, L; Khukhlina, O; Mandryk, O; Smandych, V | 1 |
| Bi, H; Cao, P; Chen, N; Chu, S; Guo, Q; He, W; Li, F; Li, X; Niu, Z; Sun, X; Zhang, Z | 1 |
| Bi, H; Chen, N; Chu, S; Cui, L; Gao, G; He, W; Li, X; Liu, F; Tian, Y; Wang, H; Wang, Z | 1 |
| Chen, N; Chu, S; Cui, L; Gao, Y; He, H; Li, J; Mo, S; Sun, X; Wang, H; Zheng, J; Zhou, X | 1 |
1 review(s) available for glycyrrhizic acid and cysteine
| Article | Year |
|---|---|
Does herbal medicine reduce the risk of hepatocellular carcinoma?
Topics: Animals; Anti-Inflammatory Agents; Benzimidazoles; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; Drugs, Chinese Herbal; Fatty Liver; Fluorenes; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plant Preparations; Sofosbuvir; Tablets | 2015 |
1 trial(s) available for glycyrrhizic acid and cysteine
| Article | Year |
|---|---|
[A double-blind study of strong neominophagen-C in treating chronic hepatitis].
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Cysteine; Double-Blind Method; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhiza; Glycyrrhizic Acid; Hepatitis; Humans; Male; Oleanolic Acid; Plants, Medicinal | 1984 |
10 other study(ies) available for glycyrrhizic acid and cysteine
| Article | Year |
|---|---|
Combination therapy with transfer factor and high dose stronger neo-minophagen C in chronic hepatitis B in children (HBe Ag positive).
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Combined Modality Therapy; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Hepatitis B e Antigens; Hepatitis, Chronic; Humans; Infant; Injections, Intravenous; Male; Oleanolic Acid; Solutions; Time Factors; Transfer Factor | 1991 |
A case of drug-induced ductopenia resulting in fatal biliary cirrhosis.
Topics: Bile Duct Diseases; Bile Ducts, Intrahepatic; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Liver; Liver Cirrhosis, Biliary; Middle Aged; Rhinitis, Allergic, Seasonal | 1993 |
Therapeutic effects of glycyrrhizin in mice infected with LP-BM5 murine retrovirus and mechanisms involved in the prevention of disease progression.
Topics: Animals; Antiviral Agents; Body Weight; CD3 Complex; Cysteine; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Immunophenotyping; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Splenomegaly | 1996 |
Vesicular drug eruption due to stronger Neo-Minophagen C.
Topics: Aged; Cysteine; Drug Combinations; Drug Eruptions; Glycine; Glycyrrhizic Acid; Humans; Injections, Intravenous; Male; Skin Diseases, Vesiculobullous | 2005 |
A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice.
Topics: Animals; Cysteine; DNA Primers; Dose-Response Relationship, Drug; Drug Combinations; Fatty Liver; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Immunoblotting; Iron; Iron, Dietary; Liver; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron, Transmission; Mitochondria; Oxidative Stress; Reactive Oxygen Species; Statistics, Nonparametric; Sterol Regulatory Element Binding Protein 1 | 2011 |
Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis.
Topics: Adult; Aged; Alanine Transaminase; Antitubercular Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Liver; Male; Middle Aged; Retrospective Studies; Risk Factors; Tuberculosis; Ursodeoxycholic Acid; Young Adult | 2016 |
EFFECTIVENESS OF NONALCOHOLIC STEATOHEPATITIS CORRECTION ON THE BAСKGROUND OF OBESITY WITH CONCOMITANT CHRONIC KIDNEY DISEASE.
Topics: Administration, Oral; Anti-Inflammatory Agents; Cysteine; Drug Administration Schedule; Drug Combinations; Extracellular Matrix; Glycine; Glycyrrhizic Acid; Humans; Injections, Intravenous; Non-alcoholic Fatty Liver Disease; Obesity; Renal Insufficiency, Chronic; Treatment Outcome | 2018 |
Combination of monoammonium glycyrrhizinate and cysteine hydrochloride ameliorated lipopolysaccharide/galactosamine-induced acute liver injury through Nrf2/ARE pathway.
Topics: Animals; Antioxidant Response Elements; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cysteine; Cytokines; Drug Combinations; Galactosamine; Glutathione; Glycyrrhizic Acid; Heme Oxygenase-1; Hepatocytes; Lipopolysaccharides; Liver; Male; Malondialdehyde; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Peroxidase; Signal Transduction; Superoxide Dismutase | 2020 |
Up-regulation of Nrf2/P62/Keap1 involves in the anti-fibrotic effect of combination of monoammonium glycyrrhizinate and cysteine hydrochloride induced by CCl
Topics: Animals; Antifibrotic Agents; Carbon Tetrachloride; Cysteine; Disease Models, Animal; Gene Knockdown Techniques; Gene Knockout Techniques; Glycyrrhizic Acid; Hep G2 Cells; Hepatocytes; Humans; Kelch-Like ECH-Associated Protein 1; Liver Cirrhosis; Male; NF-E2-Related Factor 2; Oxidative Stress; Rats; Sequestosome-1 Protein; Signal Transduction; Up-Regulation | 2021 |
Combination of monoammonium glycyrrhizinate and cysteine hydrochloride protects mice against acetaminophen-induced liver injury via Keap1/Nrf2/ARE pathway.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Cysteine; Glutathione; Glycyrrhizic Acid; Kelch-Like ECH-Associated Protein 1; Liver; Mice; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction | 2022 |